 |
|
||||||||||||||||||
    
 |
|||||||||||||||||||
| About | Ahead of print | Current Issue | Archive | Search | Instructions | Advertise | Contact |
|
|||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||
|
» Article
Access Statistics
Year : 2017 | Volume: 54 | Issue Number: 4 | Page: 664-668 ORIGINAL ARTICLEA comparative phase III clinical study to evaluate efficacy and safety of TrastuRel™ (biosimilar trastuzumab) and innovator trastuzumab in patients with metastatic human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer Apsangikar Prasad, Chaudhry Sunil, Naik Manoj, Deoghare Shashank, Joseph Jamila
|
|
||||||||
